CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission. (Q47974824)

7 February 2018

title

CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission. (English)

1 reference

7 February 2018

primary mediastinal B-cell lymphoma

1 reference

1 reference

6

Pier Luigi Zinzani

1 reference

7 February 2018

Enrico Derenzini

object named as

Enrico Derenzini

4

0 references

author name string

Vittorio Stefoni

1

1 reference

7 February 2018

Alessandro Broccoli

2

1 reference

7 February 2018

Cinzia Pellegrini

3

1 reference

7 February 2018

Mariapaola Fina

5

1 reference

7 February 2018

publication date

18 April 2009

1 reference

7 February 2018

Journal of Neuro-Oncology

published in

1 reference

7 February 2018

volume

95

1 reference

7 February 2018

issue

1

1 reference

7 February 2018

page(s)

135-139

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-009-9898-0

exact match

0 references

cites work

Primary mediastinal large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

CNS prophylaxis in lymphoma: who to target and what therapy to use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

CNS involvement in primary mediastinal large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental H

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Transient tetraparesis after intrathecal and high-dose systemic methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Acute respiratory distress syndrome following intrathecal methotrexate administration: a case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Excessive spinal cord toxicity from intensive central nervous system-directed therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9898-0

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lympho

21 January 2018

1 reference

12 December 2020

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

1 reference

12 December 2020

Acute tumor lysis syndrome following intrathecal methotrexate

1 reference

12 December 2020

Leukemias and lymphomas: treatment and prophylaxis of the central nervous system

1 reference

12 December 2020

Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features

1 reference

12 December 2020

Central nervous system lymphoma.

1 reference

12 December 2020

MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis

1 reference

12 December 2020

Primary non-Hodgkin's lymphoma of the mediastinum

1 reference

12 December 2020

Intrathecal methotrexate-induced acute cerebellar syndrome

1 reference

12 December 2020

Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy

1 reference

12 December 2020

Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.

1 reference

12 December 2020

Management of nodal diffuse large B-cell lymphomas: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

1 reference

12 December 2020

10.1007/S11060-009-9898-0

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

19381440

1 reference

7 February 2018